Treatment for Drug Resistant Tuberculosis to Boost in AfghanistanMar 27, 2017
Tuberculosis is one of the major public health issues in Afghanistan. If TB is misdiagnosed and treated irregularly with antibiotics, it develops into multidrug resistant tuberculosis. This is a severe type of the disease that is highly contagious and poses a serious public health risk.
Currently, there is only one hospital in Kabul that can treat this type of TB.
But there will soon be a rise in diagnosis and treatment of the multi-drug-resistance TB with new hospitals that will soon open in Jalalabad, Herat and Mazar-e-Sharif. Each of these 24-bed hospitals, built with UNDP and the Global Fund support, will have the capacity to treat 200 patients at a time. It takes two years to treat this deadly disease, but patients need to be hospitalized for the first six months.
TB is recorded as the world's deadliest disease in 2016. Nearly 12,000 people in Afghanistan died of tuberculosis in 2015, alone.
Check out a recent story on BBC Afghanistan about how UNDP and the Global Fund help the Public Health Ministry to fight against tuberculosis.